104 search results for: type 2 inflammation

Exploring the Mechanisms of FeNO Production in the Lungs
Pulmonology
Exploring the Mechanisms of FeNO Production in the Lungs
videoanimation

Explore how type 2 inflammation drives the production of FeNO in severe asthma

View more
CRSwNP Triathlon: An Interactive Learning Experience
Rhinology
CRSwNP Triathlon: An Interactive Learning Experience
interactivity

Embark on this interactive triathlon challenge to uncover the interplay of type 2 inflammation, barrier dysfunction, and neuroimmune dysregulation in the disease pathology of CRSwNP.

View more
<b>Type</b> <b>2</b> <b>Inflammation</b> Contributes to Itch and Fibrois in PN
Dermatology
Type 2 Inflammation Contributes to Itch and Fibrois in PN
expert video

Join Dr. Kwatra outlining the micro itch cycle involving type 2 cell polarization and cytokines that directly affect fibroblasts to cause more immune dysregulation in PN.

View more
Mechanisms of Production and Clinical Impact of IgE
Pulmonology
Mechanisms of Production and Clinical Impact of IgE
videoanimation

Explore how type 2 inflammation drives the production of IgE in severe asthma

View more
Eosinophils: A Biomarker in COPD
Pulmonology
Eosinophils: A Biomarker in COPD
Infographic

Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.

View more
ERS <b>2</b>0<b>2</b>6 | Distal Airways, Central Role? Clinical Insights Into <b>Type</b> <b>2</b> Severe Asthma
Pulmonology
ERS 2026 | Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma
expert video

Join experts Frederik Trinkmann, Monica Kraft, and Arnaud Bourdin on an ADVENT educational symposium, “Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma."

View more
IFOS <b>2</b>0<b>2</b>3 | <b>Type</b> <b>2</b> <b>Inflammation</b> and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

<b>Type</b> <b>2</b> Cytokines Have Multiple Critical Roles in BP That Contribute to <b>Inflammation</b> and Itch
Dermatology
Type 2 Cytokines Have Multiple Critical Roles in BP That Contribute to Inflammation and Itch
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Enno Schmidt highlights the role of type 2 cytokines involved in the dysregulated Type 2 immune responses that contribute to inflammation and subsequent itch in bullous pemphigoid.

View more
<b>Type</b> <b>2</b> <b>Inflammation</b> Within Skin Tissue in AD
Dermatology
Type 2 Inflammation Within Skin Tissue in AD
expert video

In this highlight video from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, Dr. Stephan Weidinger discusses how type 2 inflammation contributes to epidermal barrier dysfunction, perivascular infiltration and plasma protein leakage, and chronic itch in AD.

View more
<b>Type</b> <b>2</b> Inflammatory Diseases Can Negatively Impact Patients and Their Caregivers
Type 2 Inflammation
Type 2 Inflammatory Diseases Can Negatively Impact Patients and Their Caregivers
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof Oscar Palomares highlights the substantial impact of type 2 inflammatory diseases on the quality of life of patients and their caregivers.

View more
Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Skin Barrier Disruption and Itch
Dermatology
Role of Type 2 Inflammation in Skin Barrier Disruption and Itch
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses how type 2 inflammation contributes to epidermal barrier dysfunction and chronic itch in AD

View more
IL-4 Contributes to Systemic <b>Type</b> <b>2</b> <b>Inflammation</b> in AD
Dermatology
IL-4 Contributes to Systemic Type 2 Inflammation in AD
expert video

In this highlight video from the ADVENT AD symposium held at EADV’s 2024 Annual Meeting in Amsterdam, Dr. Stephan Weidinger discusses how IL-4 contributes to systemic type 2 inflammation in AD via several mechanisms, including T cell differentiation, B cell activation and IgE generation, and T regulatory cell inhibition.

View more